XML 39 R20.htm IDEA: XBRL DOCUMENT v3.20.4
Share Based Payments (Tables)
12 Months Ended
Dec. 31, 2020
Summary of Stock Option Activity

The following is a summary of stock option activity for the year ended December 31, 2020 and 2019:

 

 

 

 

 

 

Weighted Average

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Remaining

 

 

Weighted Average

 

 

Aggregate

 

 

 

 

 

 

 

Contractual

 

 

Exercise Price

 

 

Intrinsic Value

 

 

 

Number of Options

 

 

Life (in years)

 

 

in USD$

 

 

in USD$

 

Outstanding as of December 31, 2018

 

 

94,475

 

 

 

5.16

 

 

$

249.87

 

 

$

8,308

 

Granted

 

 

33,337

 

 

 

 

 

 

 

162.74

 

 

 

 

 

Forfeited

 

 

(13,939

)

 

 

 

 

 

 

298.55

 

 

 

 

 

Exercised (1)

 

 

(14,855

)

 

 

 

 

 

 

96.95

 

 

 

 

 

Outstanding as of December 31, 2019

 

 

99,018

 

 

 

7.78

 

 

$

236.63

 

 

$

 

Granted

 

 

42,988

 

 

 

 

 

 

$

15.20

 

 

 

 

 

Forfeited/Cancelled

 

 

(28,448

)

 

 

 

 

 

 

210.57

 

 

 

 

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2020

 

 

113,558

 

 

 

7.75

 

 

$

159.33

 

 

$

 

Exercisable as of December 31, 2020

 

 

57,725

 

 

 

6.56

 

 

$

117.90

 

 

$

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) For the year ended December 31, 2019, 14,855 stock options were exercised on a cashless basis resulting in 13,818 shares being withheld in satisfaction of the exercise price.

 

Summary of Company's Restricted Stock Unit Activity

The following is a summary of the Company’s RSU activity for the years ended December 31, 2020 and 2019:

 

 

Number of Restricted Stock Units

 

 

Weighted Average Grant Date Fair Value per Unit

Outstanding as of December 31, 2018

 

 

27

 

 

CAD$350.00

Granted

 

 

788

 

 

USD$21.17

Vested and settled during 2019 (1)

 

 

(27

)

 

CAD$350.00

Outstanding as of December 31, 2019

 

 

788

 

 

USD$21.17

Granted

 

 

7,172

 

 

USD$15.25

Settled during 2020

 

 

(7,792

)

 

USD$17.81

Outstanding as of December 31, 2020

 

 

168

 

 

USD$13.20

 

 

 

 

 

 

 

(1) Includes 7 RSUs withheld to satisfy required withholding taxes.

 

 

 

 

 

 

Summary of Stock-Based Compensation Expense is Classified in Condensed Consolidated Statements of Operations and Comprehensive Loss

 

Stock-Based Compensation Expense

Stock-based compensation expense is classified in the Company’s consolidated statements of operations and comprehensive loss as follows (amounts in thousands):

 

 

2020

 

 

2019

 

Research and development

 

$

933

 

 

$

898

 

Cost of sales

 

$

(1

)

 

 

 

General and administrative

 

 

1,597

 

 

 

3,793

 

Total

 

$

2,529

 

 

$

4,691

 

Employee and Director Stock Options  
Estimation Using Black-Scholes Option Pricing Model With Following Weighted Average Assumptions The fair value of employee and director stock options granted for the years ended December 31, 2020 and 2019 had a weighted average grant date fair value of $9.71 and $105.38 per option, respectively, and they were estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

Year Ended December 31,

 

 

 

2020

 

 

2019

 

Stock price

 

$15.23

 

 

$162.74

 

Exercise price

 

$15.23

 

 

$162.74

 

Expected term

 

5.32 years

 

 

5.42 years

 

Expected volatility

 

 

75.35

%

 

 

76.90

%

Risk-free interest rate

 

 

0.52

%

 

 

1.96

%

Dividend rate

 

 

0.00

%

 

 

0.00

%

 

Consultants Stock Options  
Estimation Using Black-Scholes Option Pricing Model With Following Weighted Average Assumptions Stock options granted to the Company’s consultants for the year ended December 31, 2020 had a weighted average grant date fair value of $8.18 per share, and they were estimated using the Black-Scholes option-pricing model with the following weighted-average assumptions:

 

 

 

Year Ended December 31,

 

 

 

2020

 

Stock price

 

$13.58

 

Exercise price

 

$13.58

 

Option term

 

5.27 years

 

Expected volatility

 

 

73.15

%

Risk-free interest rate

 

 

0.33

%

Dividend rate

 

 

0.00

%